Almost no hospitals in the California Veteran's Administration system adhere to national guidelines that recommend the use of a clinical decision rule and a D-dimer test before patients with pulmonary embolism are referred for CT pulmonary angiography, new research shows.
All news from Radio Diagnosis
The US Food and Drug Administration (FDA) has approved a new molecular assay, ID CORE XT (Progenika Biopharma), for use in transfusion medicine to help determine blood compatibility between donor and patient for non-ABO red blood cell types.
About 15% of breast cancers are classified as triple-negative, lacking receptors for estrogen, progesterone, and Her2. These cancers do not respond to targeted hormonal therapies, and they tend to be particularly aggressive, often resisting systemic chemotherapy and metastasizing to other tissues.
A Wilmot Cancer Institute study uncovers how a single gene could be at fault in acute myeloid leukemia (AML), one of the deadliest cancers. The breakthrough gives researchers renewed hope that a gene-targeted therapy could improve AML survival rates, which have not budged in recent years.
Researchers from Brown University and Rhode Island Hospital have been at the forefront of battling the opioid epidemic in Rhode Island, and a new $800,000 grant from the Laura and John Arnold Foundation will help them to keep up the fight.
Failed back surgery (continued low back and leg pain after surgery) is relatively common. With each reoperation, success, as defined by pain reduction, becomes less likely and most patients do not improve.
Acetaminophen is a common pain reliever found in every pharmacy. However, it is also the No. 1 cause of acute liver failure in the United States. In the liver, acetaminophen is converted into a new compound that covalently binds to proteins at an amino acid called cysteine.
Dr. Mark McPhail from the Department of Inflammation Biology, School of Immunology & Microbial Sciences and Dr. Vishal Patel from the Institute of Liver Studies at King's College Hospital have been awarded £ 2.3 million by the National Institute of Health Research Health Technology Assessment (NIHR HTA).
Health insurance has become a buzz word, thanks to the Pradhan Mantri Jan Arogya Yojana that promises to insure 500 million people from the lower economic strata, and the insurance regulator’s renewed focus on it. Tapan Singhel, managing director and CEO, Bajaj Allianz General Insurance Co. Ltd, talks about how the health insurance landscape is expected to evolve